Kenvue Inc. (1KVUE)
MTA
Closed
Aug 21, 2026
Day's Range
16.3252 wk Range
12.16Overview - 1KVUE - Kenvue Inc.
Key Statistics
Valuation
Enterprise Value
33.22B
P/E (Trailing)
‪22.38‬
PEG Ratio
‪2.46‬
Price / Sales (TTM)
‪2.03‬
Price / Book
‪3.47‬
EV / EBITDA
‪11.17‬
Profitability
Gross Margin
‪58.17%‬
Profit Margin
‪10.76%‬
Operating Margin
‪19.41%‬
Return on Assets
‪6.99%‬
Return on Equity
‪15.58%‬
Ownership
Shares Outstanding
1.91B
Float
1.91B
Held by Insiders
‪0.07%‬
Held by Institutions
‪95.94%‬
Price stats
Beta
‪0.43‬
50-Day Avg
‪16.68‬
200-Day Avg
‪15.42‬
Dividends
Payout Ratio
‪97.65%‬
Frequency
Quarterly
Market Cap - 1KVUE - Kenvue Inc.
Peers - 1KVUE - Kenvue Inc.
Peer Comparison
Compared with companies in Household & Personal Products listed on MTA.
Profile Summary - 1KVUE - Kenvue Inc.
About
Kenvue Inc. is the world's largest pure-play consumer health company, specializing in science-backed products for everyday care needs. It operates through three key segments: Self Care, offering cough, cold, allergy, pain, digestive health, smoking cessation, and eye care under brands like Tylenol, Motrin, Benadryl,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
